Suzanne Meeves

710 total citations
32 papers, 522 citations indexed

About

Suzanne Meeves is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Suzanne Meeves has authored 32 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 9 papers in Immunology and Allergy and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Suzanne Meeves's work include Asthma and respiratory diseases (12 papers), Allergic Rhinitis and Sensitization (9 papers) and Respiratory and Cough-Related Research (7 papers). Suzanne Meeves is often cited by papers focused on Asthma and respiratory diseases (12 papers), Allergic Rhinitis and Sensitization (9 papers) and Respiratory and Cough-Related Research (7 papers). Suzanne Meeves collaborates with scholars based in United States, Australia and Belgium. Suzanne Meeves's co-authors include Sireesh Appajosyula, George Georges, Yuning Liao, Paul D. Miller, Kenneth G. Saag, Thomas Lang, Steven Boonen, Sheldon L. Spector, Pierre D. Delmas and Robert Lindsay and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Allergy and Clinical Immunology and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Suzanne Meeves

29 papers receiving 484 citations

Peers

Suzanne Meeves

PHYSI

OSM

ONCOL

Pietro Buono Italy

Jolene Mason United States

W. Stricker United States

Hiroshi Koto Japan

Young‐Ok Kim South Korea

Ruth Bolier Netherlands

Román Valiente Spain

Ursula M. Ney United Kingdom

Lilian E. Murchison United Kingdom

Pietro Buono Italy

Suzanne Meeves

12 ×0.1

107 ×0.6

PHYSI

75 ×0.5

OSM

51 ×0.4

ONCOL

185 ×2.0

Citations per year, relative to Suzanne Meeves Suzanne Meeves (= 1×) peers Pietro Buono

Countries citing papers authored by Suzanne Meeves

Since Specialization

Citations

This map shows the geographic impact of Suzanne Meeves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Meeves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Meeves more than expected).

Fields of papers citing papers by Suzanne Meeves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Meeves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Meeves. The network helps show where Suzanne Meeves may publish in the future.

Co-authorship network of co-authors of Suzanne Meeves

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Meeves. A scholar is included among the top collaborators of Suzanne Meeves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Meeves. Suzanne Meeves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meeves, Suzanne, et al.. (2023). 2.22 Evaluation of Dermal Irritation with the Dextroamphetamine Transdermal System (d-ATS) in Healthy Adults and Patients With ADHD. Journal of the American Academy of Child & Adolescent Psychiatry. 62(10). S187–S188.

Cutler, Andrew J., et al.. (2023). d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivotal Trial. Journal of Child and Adolescent Psychopharmacology. 33(5). 176–182. 3 indexed citations

Cutler, Andrew J., et al.. (2022). Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study. Journal of Child and Adolescent Psychopharmacology. 32(2). 89–97. 12 indexed citations

Tarabar, Sanela, Debra Kelsh, Bradley Vince, et al.. (2020). Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations. Drugs in R&D. 20(1). 23–37. 10 indexed citations

Jayawardena, Shyamalie, et al.. (2017). Brompheniramine and Chlorpheniramine Pharmacokinetics Following Single‐Dose Oral Administration in Children Aged 2 to 17 Years. The Journal of Clinical Pharmacology. 58(4). 494–503. 5 indexed citations

Meeves, Suzanne, et al.. (2015). (401) Analgesic effectiveness of a new, extended-release ibuprofen in postoperative dental pain. Journal of Pain. 16(4). S76–S76. 2 indexed citations

Miller, Paul D., Pierre D. Delmas, Robert Lindsay, et al.. (2008). Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate. The Journal of Clinical Endocrinology & Metabolism. 93(10). 3785–3793. 149 indexed citations

Berkowitz, Robert, et al.. (2006). Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis. Annals of Allergy Asthma & Immunology. 96(2). 327–333. 13 indexed citations

Berkowitz, Robert, et al.. (2006). Onset of action of fexofenadine hydrochloride 60 mg/ pseudoephedrine hydrochloride 120 mg in subjects aged ⩾ 12 years with moderate to severe seasonal allergic Rhinitis: A pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies. Clinical Therapeutics. 28(10). 1658–1669. 10 indexed citations

10.

Kaplan, Allen P., Sheldon L. Spector, Suzanne Meeves, et al.. (2005). Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Annals of Allergy Asthma & Immunology. 94(6). 662–669. 44 indexed citations

11.

White, Martha V., et al.. (2005). Comparative effects of fexofenadine and montelukast on allergen-induced wheal and flare.. PubMed. 26(3). 221–8. 7 indexed citations

12.

Berkowitz, Robert, et al.. (2005). Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.. PubMed. 25(5). 335–43. 8 indexed citations

13.

Kaliner, Michael, Martha V. White, Athena Economides, et al.. (2003). Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression. Annals of Allergy Asthma & Immunology. 90(6). 629–634. 16 indexed citations

14.

Mansfield, Lyndon E., et al.. (2003). Effects of fexofenadine, diphenhydramine, and placebo on performance of the Test of Variables of Attention (TOVA). Annals of Allergy Asthma & Immunology. 90(5). 554–559. 19 indexed citations

15.

Meeves, Suzanne & Sireesh Appajosyula. (2003). Efficacy and safety profile of fexofenadine HCL. Journal of Allergy and Clinical Immunology. 112(4). S69–S77. 38 indexed citations

16.

Berkowitz, Robert, et al.. (2002). Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit. Annals of Allergy Asthma & Immunology. 89(1). 38–45. 31 indexed citations

17.

Mohler, Stanley R., et al.. (2002). The Use of Antihistamines in Safety-critical Jobs: A Meeting Report. Current Medical Research and Opinion. 18(6). 332–337. 8 indexed citations

18.

Meeves, Suzanne, Kerry B. Hafner, Glen Park, & Michael A. Weber. (1995). Three-period crossover trial with ambulatory blood pressure monitoring for evaluating antihypertensive therapy. American Heart Journal. 130(4). 841–848. 2 indexed citations

19.

Meeves, Suzanne & Glen D. Park. (1994). The Use of Confidence Intervals to Describe the Precision of Trough/Peak Ratios for Diltiazem CD in the Treatment of Hypertension. The Journal of Clinical Pharmacology. 34(3). 231–235. 5 indexed citations

20.

Meeves, Suzanne, et al.. (1993). Calcium-Channel Antagonists for Prevention of Atherosclerosis. Annals of Pharmacotherapy. 27(1). 61–67. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact